Executive Summary

Type of Business
Our client is a professional services firm successfully using the Internet to collect and deliver market research to companies selling to the global life sciences industry. This industry consists of a broad range of companies that sell approximately $70 billion in products and services used in drug discovery, testing and basic scientific and medical research. The Company’s business model, existing assets and domain expertise can be leveraged to create new products and services that will capture a larger percentage of its clients’ collective $20 billion expenditures to support strategic planning, marketing and sales.

Overview
Since 1994, The Company has executed over 500 market research studies and serviced over 300 unique customers. Its customer base is diverse—the top 20 customers represent only 36% of revenue. The Company’s customers are also loyal— approximately 72% of annual revenue is generated from repeat customers. Using proven consumer research methodologies, the Company has helped clients enter new markets, launch new products, conduct acquisition due diligence, monitor customer satisfaction and develop marketing strategies.

In addition to companies selling to life science firms, the firm also works with other clients with an interest in the scientific market, including pharmaceutical and biotechnology companies, financial institutions, information technology vendors, advertising and consulting firms, publishers, non-profit societies and government agencies.

The Company is an innovator and was among the first market research firms to grasp the potential of the Internet to facilitate the communication of valuable information between buyers and sellers. As a result of its data collection efforts, the Company now offers instant access to the world's largest online panel of scientific experts — enabling it to answer a
client's most critical questions in real time. In addition, the Company has created a vast database containing detailed profiles of 230,000 of the world’s biomedical researchers and 46,000 industry executives. By exploiting XML and RSS technologies, this database of information can be repurposed, repackaged and resold to different segments and life sciences audiences at a small incremental cost.

The Company will consider a capital investment or merger partner. Management estimates $2 million in expansion capital will enable the Company to execute on its plan to quadruple in size to $8 million by leveraging its information gathering capabilities to provide more high value content to the life science industry’s suppliers and consumers via a range of media formats.

Financial History & Projection Summary
(in thousands, source: Company Management)

Contact Details:
Craig O. Allsopp CBI
Strategic Exit Advisors LLC
215-489-8881 or coallsopp@seadvisorsllc.com

This executive summary is provided on a confidential basis for discussion purposes only.
Copyright © 2008 Strategic Exit Advisors LLC

< back to Current Engagements